src: 2.bp.blogspot.com
Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome however its use as a potential antipsychotic drug for the treatment of schizophrenia has been discontinued.
Video Talnetant
See also
- Fezolinetant
- MLE-4901
- Osanetant
Maps Talnetant
References
Source of the article : Wikipedia